Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD300f Rat anti-Mouse, Clone: 305835, Invitrogen™

Rat Monoclonal Antibody

Manufacturer:  Invitrogen MA524018

Catalog No. PIMA524018

This item has been discontinued by the manufacturer and is no longer available. Please call customer service for assistance: 1-800-766-7000.


Description

Description

In direct ELISAs, no cross-reactivity with recombit mouse (rm) LMIR4, rmCD300b/LMIR5, recombit human (rh) CD300a/LMIR1, rhCD300c/LMIR2, rhCD300f/LMIR3, or rhCD300e/LMIR6 is observed. Reconstitute at 0.5 mg/mL in sterile PBS.

CLM1 is an inhibitory receptor of the Ig superfamily expressed on myeloid cells. It mediates negative regulatory signals by recruiting SHP1 (PTPN6, MIM 176883) or SHIP.
Specifications

Specifications

CD300f
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Q6SJQ7
CD300f, CLM-1, CLM1, IREM-1, IREM1, IgSF13, NKIR, CD300 antigen like family member F, CD300 antigen-like family member F, CD300 molecule like family member f, CMRF35-like molecule 1, NK inhibitory receptor, immune receptor expressed on myeloid cells 1, immunoglobin superfamily member 13, immunoglobulin superfam
Rat
IgG1
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
246746
Flow Cytometry, Western Blot
305835
Unconjugated
Cd300lf
Lyophilized
CD300LF
Mouse myeloma cell line NS0-derived recombit mouse CD300f/LMIR3 Cys16-Gly188
Protein A/G
RUO
Antibody
Monoclonal
Mouse
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit